Legend Biotech (LEGN) Return on Capital Employed (2020 - 2025)
Legend Biotech (LEGN) posted Return on Capital Employed of 51.73% for Q4 2025, up 30.48% on a QoQ basis from 39.64% in Q3 2025, and up 2665.0% year-over-year from 1.87% in Q4 2024.
Legend Biotech (LEGN) has 6 years of Return on Capital Employed data on file, last reported at 51.73% in Q4 2025.
- In Q4 2025, Return on Capital Employed rose 2665.0% year-over-year to 51.73%; the TTM figure through Dec 2025 stood at 51.73% (up 2665.0% YoY), while the FY2025 annual figure was 12.81%, up 808.0% from the prior year.
- Return on Capital Employed advanced to 51.73% in Q4 2025, from 39.64% in the prior quarter.
- Across five years, Return on Capital Employed topped out at 5372.09% in Q2 2024 and bottomed at 2307.76% in Q3 2021.
- A 5-year average of 999.88% and a median of 39.64% in 2025 frame the typical range for Return on Capital Employed.
- Annual changes were most pronounced in 2024 — Return on Capital Employed jumped 533217 bps — and 2025, when it slumped 533780 bps.
- Year by year, Return on Capital Employed stood at 1781.34% in 2021, then soared by 103 bps to 45.59% in 2022, then surged by 10676 bps to 4913.13% in 2023, then tumbled by 99 bps to 25.08% in 2024, then soared by 106 bps to 51.73% in 2025.
- The last three Return on Capital Employed figures came in at 51.73% (Q4 2025), 39.64% (Q3 2025), and 34.29% (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 450.31% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 51.73% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -107.40% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 21.10% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 10.19% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 20.34% |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | -21.94% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 51.73% |
| Sep 30, 2025 | 39.64% |
| Jun 30, 2025 | 34.29% |
| Mar 31, 2025 | 31.40% |
| Dec 31, 2024 | 25.08% |
| Sep 30, 2024 | 5,340.57% |
| Jun 30, 2024 | 5,372.09% |
| Mar 31, 2024 | 5,123.67% |
| Dec 31, 2023 | 4,913.13% |
| Sep 30, 2023 | 35.62% |
| Jun 30, 2023 | 39.93% |
| Mar 31, 2023 | 42.87% |
| Mar 31, 2022 | 45.59% |
| Dec 31, 2021 | -1,781.34% |
| Sep 30, 2021 | -2,307.76% |
| Jun 30, 2021 | -4.27% |
| Mar 31, 2021 | -4.28% |
| Dec 31, 2020 | 0.08% |
| Sep 30, 2020 | 0.04% |